Key statistics
As of last trade Omeros Corp (3O8:STU) traded at 9.74, -32.55% below its 52-week high of 14.44, set on Jan 02, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 9.38 |
|---|---|
| High | 10.15 |
| Low | 9.31 |
| Bid | 9.81 |
| Offer | 9.88 |
| Previous close | 9.58 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | 70.90m |
| Free float | 68.92m |
| P/E (TTM) | -- |
| Market cap | 828.83m USD |
| EPS (TTM) | -2.04 USD |
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Press releases
- Omeros Announces First Commercial Sales of YARTEMLEA®
- Omeros Announces New Date for YARTEMLEA® Approval Conference Call
- FDA Approves Omeros’ YARTEMLEA® – First and Only Therapy Indicated for TA-TMA
- Omeros Corporation Announces Closing of Asset Purchase and License Agreement with Novo Nordisk for Omeros’ Clinical-Stage MASP-3 Inhibitor Zaltenibart (OMS906)
